Probing the Molecular Assembly of a Metabolizer Drug with β-Cyclodextrin and Its Binding with CT-DNA in Augmenting Antibacterial Activity and Photostability by Physicochemical and Computational Methodologies

Citations Over TimeTop 25% of 2022 papers

Abstract

The assembly of an inclusion complex in an aqueous medium using a metabolizer drug (dyphylline) as guest and β-cyclodextrin as host has been established, which is extremely appropriate for a variety of applications in modern biomedical sciences. The formation of the inclusion complex is established by 1H NMR, and surface tension and conductivity measurements demonstrate that the inclusion complex was produced with 1:1 stoichiometry. The thermodynamic parameters based on density, viscosity, and refractive index measurements were used to determine the nature of the complex. This research also forecasts how dyphylline will release in the presence of CT-DNA without any chemical modifications. The produced insertion complex (IC) has a higher photostability due to the drug dyphylline being protected by β-CD. The antibacterial activity of dyphylline greatly improved after complexation and exhibited higher toxicity against Gram-negative (highest against Escherichia coli) in comparison to Gram-positive bacteria. The encapsulation mode of the dyphylline molecule into the cavity of the β-CD was also investigated using DFT to confirm preliminary results.

Related Papers

• → Difference in the complexation of cholesterol with β-cyclodextrin derivatives: A combined theoretical and experimental study(2023)20 cited
• → Inclusion complexes of squalene with beta-cyclodextrin and methyl-beta-cyclodextrin: preparation and characterization(2023)8 cited
• → Rayleigh light scattering study on the supramolecular interactions of β-cyclodextrin derivatives with tetrakis(4-methoxylphenyl)porphyrin(2002)12 cited
• Comparative study on inclusion complexation of beta-cyclodextrin and tri-O-methyl-beta-cyclodextrin with several drugs in aqueous solution.(1984)
• [The local anesthetic activity of inclusion compounds of pirbentan and trimecaine with beta-cyclodextrin].(1995)